<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="EN" hierarchy="1" humanitarian="4" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>GB-GOV-13-FUND--GCRF-MR_M026469_1</iati-identifier>
  <reporting-org ref="10" type="DEPARTMENT OF BUSINESS, ENERGY AND INDUSTRIAL STRATEGY">
   <narrative xml:lang="EN">1</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Is Lactoferrin more effective than inorganic iron in treating iron def anaemia in non-pregnant and if effective in pregnant women? 2 randomised trials</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">4</narrative>
  </description>
  <description type="1">
   <narrative xml:lang="EN">Oral bovine lactoferrin is a novel, unconventional way to prevent low birthweight, preterm birth &amp; neonatal deaths associated with maternal iron deficiency in low income settings. Each year about 20 million low birthweight babies are born worldwide. Low birthweight is caused by either preterm delivery (babies born earlier than expected) or fetal growth retardation. In countries where perinatal health services are limited, low birthweight and preterm birth are a major cause of neonatal deaths. Low birthweight babies are 20 or more times likely to die than heavier babies, with much of this mortality burden due to preterm birth. The current paradigm of using iron supplements (and folic acid) targeted at pregnant women often fails, in part because of the side effects, which are a strong barrier to use of the supplements early in pregnancy, a period of vulnerability for iron deficient women and their fetus and future newborn. And also because maternal inflammation and micronutrient deficiencies block effective utilization of iron Our approach will provide a product that will efficiently deliver iron and that can be taken early in pregnancy during a critical intervention window, which offers the potential to prevent neonatal deaths.</narrative>
  </description>
  <other-identifier type="GB-GOV-13"></other-identifier>
  <activity-status code="2015-03-01"></activity-status>
  <activity-date iso-date="2015-05-26" type="2"></activity-date>
  <activity-date iso-date="2017-08-31" type="3"></activity-date>
  <activity-date iso-date="2018-11-25" type="4"></activity-date>
  <activity-date iso-date="BD" type="BANGLADESH"></activity-date>
  <contact-info type="UK RESEARCH &amp; INNOVATION">
   <organisation>
    <narrative xml:lang="EN">International Development</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">GCRF</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">gcrf@ukri.org</narrative>
   </person-name>
   <email>https://www.ukri.org/</email>
   <website>Polaris House, Swindon, SN2 1LF</website>
   <mailing-address>
    <narrative xml:lang="EN">GBP</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="SOUTH &amp; CENTRAL ASIA, REGIONAL" percentage="100">
   <narrative xml:lang="EN">689</narrative>
  </recipient-country>
  <recipient-region code="1" percentage="100" vocabulary="RESEARCH/SCIENTIFIC INSTITUTIONS"></recipient-region>
  <sector percentage="100" vocabulary="1">
   <narrative xml:lang="EN">43082</narrative>
  </sector>
  <collaboration-type code="10"></collaboration-type>
  <default-flow-type code="110"></default-flow-type>
  <default-finance-type code="D02"></default-finance-type>
  <default-aid-type code="5" vocabulary="1"></default-aid-type>
  <budget status="2" type="1">
   <period-start iso-date="2015-04-01"></period-start>
   <period-end iso-date="2015-03-31"></period-end>
   <value currency="GBP" value-date="2015-01-16">50776.41</value>
  </budget>
  <budget status="2" type="1">
   <period-start iso-date="2016-04-01"></period-start>
   <period-end iso-date="2016-03-31"></period-end>
   <value currency="GBP" value-date="2015-01-16">62701.09</value>
  </budget>
  <budget status="2" type="1">
   <period-start iso-date="2017-04-01"></period-start>
   <period-end iso-date="2017-03-31"></period-end>
   <value currency="GBP" value-date="2015-01-16">24424.31</value>
  </budget>
  <capital-spend percentage="I. To determine whether bovine Lactoferrin is more effective than oral iron in treating iron deficiency anaemia among non-pregnant women of reproductive age and if effective in pregnant women. II. To compare the side-effects of oral iron supplements and bovine Lactoferrin III. To compare the compliance of oral iron supplements and bovine Lactoferrin IV. To determine the most effective dose of oral bovine Lactoferrin for correction and prevention of iron deficiency anaemia."></capital-spend>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-04-01"></transaction-date>
   <value currency="GBP" value-date="2016/17 FY Q1">16925.45</value>
   <description>
    <narrative xml:lang="EN">Quarterly Payment for the GCRF funded activity</narrative>
   </description>
   <provider-org provider-activity-id="GB-GOV-13-FUND--GCRF-MR_M026469_1" ref="GB-GOV-13">
    <narrative xml:lang="EN">UK - Department for Business, Energy and Industrial Strategy</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">ICDDRB</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-07-01"></transaction-date>
   <value currency="GBP" value-date="2016/17 FY Q2">16268</value>
   <description>
    <narrative xml:lang="EN">Quarterly Payment for the GCRF funded activity</narrative>
   </description>
   <provider-org provider-activity-id="GB-GOV-13-FUND--GCRF-MR_M026469_1" ref="GB-GOV-13">
    <narrative xml:lang="EN">UK - Department for Business, Energy and Industrial Strategy</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">ICDDRB</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-10-01"></transaction-date>
   <value currency="GBP" value-date="2016/17 FY Q3">16089.9</value>
   <description>
    <narrative xml:lang="EN">Quarterly Payment for the GCRF funded activity</narrative>
   </description>
   <provider-org provider-activity-id="GB-GOV-13-FUND--GCRF-MR_M026469_1" ref="GB-GOV-13">
    <narrative xml:lang="EN">UK - Department for Business, Energy and Industrial Strategy</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">ICDDRB</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-01-01"></transaction-date>
   <value currency="GBP" value-date="2016/17 FY Q4">13417.7</value>
   <description>
    <narrative xml:lang="EN">Quarterly Payment for the GCRF funded activity</narrative>
   </description>
   <provider-org provider-activity-id="GB-GOV-13-FUND--GCRF-MR_M026469_1" ref="GB-GOV-13">
    <narrative xml:lang="EN">UK - Department for Business, Energy and Industrial Strategy</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">ICDDRB</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-04-01"></transaction-date>
   <value currency="GBP" value-date="2017/18 FY Q1">13417.7</value>
   <description>
    <narrative xml:lang="EN">Quarterly Payment for the GCRF funded activity</narrative>
   </description>
   <provider-org provider-activity-id="GB-GOV-13-FUND--GCRF-MR_M026469_1" ref="GB-GOV-13">
    <narrative xml:lang="EN">UK - Department for Business, Energy and Industrial Strategy</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">ICDDRB</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-10-01"></transaction-date>
   <value currency="GBP" value-date="2017/18 FY Q3">11006.6</value>
   <description>
    <narrative xml:lang="EN">Quarterly Payment for the GCRF funded activity</narrative>
   </description>
   <provider-org provider-activity-id="GB-GOV-13-FUND--GCRF-MR_M026469_1" ref="GB-GOV-13">
    <narrative xml:lang="EN">UK - Department for Business, Energy and Industrial Strategy</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">ICDDRB</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-10-01"></transaction-date>
   <value currency="GBP" value-date="2019/20 FY Q3">11006.55</value>
   <description>
    <narrative xml:lang="EN">Quarterly Payment for the GCRF funded activity</narrative>
   </description>
   <provider-org provider-activity-id="GB-GOV-13-FUND--GCRF-MR_M026469_1" ref="GB-GOV-13">
    <narrative xml:lang="EN">UK - Department for Business, Energy and Industrial Strategy</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">ICDDRB</narrative>
   </receiver-org>
  </transaction>
  <document-link format="HTTPS://WWW.UKRI.ORG/FUNDING/INFORMATION-FOR-AWARD-HOLDERS/GRANT-TERMS-AND-CONDITIONS/" url="A04">
   <title>
    <narrative xml:lang="EN">application/pdf</narrative>
   </title>
   <category code="0"></category>
  </document-link>
  <conditions attached="UK Research &amp; Innovation Grant Terms and Conditions"></conditions>
  <iati-activities>
   <iati-activity>
    <title>
     <narrative xml:lang="2021-09-24"></narrative>
    </title>
   </iati-activity>
  </iati-activities>
 </iati-activity>
</iati-activities>
